137 related articles for article (PubMed ID: 38277030)
1. Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia.
Beale F; Gkiourtzis N; Koneru S; O'Brien C; Lalayiannis AD
Pediatr Nephrol; 2024 Aug; 39(8):2355-2358. PubMed ID: 38277030
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia associated with
Coche S; Cornet G; Morelle J; Labriola L; Kanaan N; Demoulin N
Acta Clin Belg; 2021 Feb; 76(1):75-78. PubMed ID: 31470765
[No Abstract] [Full Text] [Related]
3. Hypercalcemia and pneumocystis Pneumonia after kidney transplantation: report of an exceptional case and literature review.
Chatzikyrkou C; Clajus C; Haubitz M; Hafer C
Transpl Infect Dis; 2011 Oct; 13(5):496-500. PubMed ID: 21414118
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jirovecii pneumonia with an atypical granulomatous response after kidney transplantation.
Ramalho J; Bacelar Marques ID; Aguirre AR; Pierrotti LC; de Paula FJ; Nahas WC; David-Neto E
Transpl Infect Dis; 2014 Apr; 16(2):315-9. PubMed ID: 24621124
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.
Hamroun A; Lenain R; Bui Nguyen L; Chamley P; Loridant S; Neugebauer Y; Lionet A; Frimat M; Hazzan M
Sci Rep; 2019 Aug; 9(1):12508. PubMed ID: 31467367
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia.
Chen WC; Chang SC; Wu TH; Yang WC; Tarng DC
Am J Kidney Dis; 2002 Feb; 39(2):E8. PubMed ID: 11840399
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury Secondary to Hypercalcemia in a Kidney Transplant Patient With Pneumocystis jirovecii Pneumonia: A Case Report.
Mascia G; Argiolas D; Carta E; Michittu MB; Piredda GB
Transplant Proc; 2019; 51(1):220-222. PubMed ID: 30736974
[TBL] [Abstract][Full Text] [Related]
8. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
Yau AA; Farouk SS
BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
[TBL] [Abstract][Full Text] [Related]
9. Unique presentation of late-onset Pneumocystis pneumonia in a pediatric kidney transplant recipient.
Grewal M; Srivastava R; Ang JY; Salimnia H; Jain A
Pediatr Transplant; 2023 Sep; 27(6):e14576. PubMed ID: 37448256
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
12. [Pneumocystis pneumonia in a renal transplant recipient].
Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
[TBL] [Abstract][Full Text] [Related]
13. New-Onset Hypercalcemia After Renal Transplant: An Infectious Etiology Beyond Persistent Hyperparathyroidism.
Koymen G; Celtik A; Cinkooglu A; Toz S; Asci G; Arda B; Toz H; Erdinc M
Exp Clin Transplant; 2022 Jul; 20(7):691-694. PubMed ID: 34142941
[TBL] [Abstract][Full Text] [Related]
14. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.
Azar MM; Cohen E; Ma L; Cissé OH; Gan G; Deng Y; Belfield K; Asch W; Grant M; Gleeson S; Koff A; Gaston DC; Topal J; Curran S; Kulkarni S; Kovacs JA; Malinis M
Clin Infect Dis; 2022 Mar; 74(4):639-647. PubMed ID: 34017984
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
[TBL] [Abstract][Full Text] [Related]
16. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
Schürmann M; Schürmann D; Schindler R; Meisel C; Liman P; Kruse J; Enghard P; König J; Schmidt D; Reinke P; Nickel P
Transpl Immunol; 2013 Jun; 28(4):159-63. PubMed ID: 23684946
[TBL] [Abstract][Full Text] [Related]
17. Successful management of concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in kidney transplant recipients: a case series.
Li G; Ji D; Chang Y; Tang Z; Cheng D
BMC Pulm Med; 2023 Nov; 23(1):458. PubMed ID: 37990199
[TBL] [Abstract][Full Text] [Related]
18. The Changing Landscape of Pneumocystis Jiroveci Infection in Kidney Transplant Recipients: Single-Center Experience of Late-Onset Pneumocystis Pneumonia.
Marinaki S; Vallianou K; Melexopoulou C; Lionaki S; Darema M; Lambrou P; Boletis I
Transplant Proc; 2021 Jun; 53(5):1576-1582. PubMed ID: 33962778
[TBL] [Abstract][Full Text] [Related]
19. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
[TBL] [Abstract][Full Text] [Related]
20. [Severe hypoxemic respiratory failure caused by Pneumocystis jirovecii in a late kidney transplant recipient].
Nieto-Ríos JF; Zuluaga-Quintero M; Aristizábal-Alzate A; Ocampo-Kohn C; Serna-Higuita LM; Ramírez-Sánchez IC; Zuluaga-Valencia GA
Biomedica; 2018 Mar; 38(1):32-36. PubMed ID: 29668131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
